Emerald Mutual Fund Advisers Trust Karuna Therapeutics, Inc. Transaction History

Emerald Mutual Fund Advisers Trust

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Oct 26, 2023	SELL	$164.66 - $218.08 $1.03 Million - $1.37 Million	-6,278 Reduced 27.63%	16,445 $2.78 Million
Q2 2023 Aug 10, 2023	SELL	$176.32 - $240.22 $7.1 Million - $9.68 Million	-40,277 Reduced 63.93%	22,723 $4.93 Million
Q1 2023 May 04, 2023	SELL	$161.33 - $204.36 $2.66 Million - $3.36 Million	-16,466 Reduced 20.72%	63,000 $11.4 Million
Q4 2022 Feb 03, 2023	SELL	$191.53 - $236.82 $3.3 Million - $4.08 Million	-17,240 Reduced 17.83%	79,466 $15.6 Million
Q3 2022 Oct 25, 2022	SELL	$123.79 - $277.42 $651,754 - $1.46 Million	-5,265 Reduced 5.16%	96,706 $21.8 Million
Q2 2022 Jul 29, 2022	SELL	$93.97 - $143.33 $10.2 Million - $15.5 Million	-108,113 Reduced 51.46%	101,971 $12.9 Million
Q1 2022 Apr 29, 2022	SELL	$98.9 - $132.37 $1.92 Million - $2.56 Million	-19,371 Reduced 8.44%	210,084 $26.6 Million
Q4 2021 Feb 02, 2022	BUY	$110.64 - $159.4 $13 Million - $18.8 Million	117,851 Added 105.6%	229,455 $30.1 Million
Q3 2021 Oct 28, 2021	SELL	$101.2 - $125.87 $8.85 Million - $11 Million	-87,492 Reduced 43.94%	111,604 $13.7 Million
Q2 2021 Jul 29, 2021	BUY	$107.45 - $135.95 $1.84 Million - $2.33 Million	17,120 Added 9.41%	199,096 $22.7 Million
Q1 2021 Apr 29, 2021	BUY	$95.46 - $133.08 $17.4 Million - $24.2 Million	181,976 New	181,976 $21.9 Million

332K

Ticker KRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 33,965,000
Description
Karuna Therapeutics, Inc., a clinical-stage biopharmaceutical company, creates and delivers transformative medicines for people living with psychiatric and neurological conditions. Its lead product candidate is KarXT, an oral modulator of muscarinic receptors that is in Phase III clinical trial for the treatment of acute psychosis in patients wi...

Get notified when there are updates to the investment portfolio of Emerald Mutual Fund Advisers Trust, based on Form 13F filings with the SEC.

Stay updated on Emerald Mutual Fund Advisers Trust with notifications on news.